Stimcell Energetics (STME) Net Cash Flow (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -190.48% |
| Nov 30, 2025 | 592.63% |
| Aug 31, 2025 | -206.22% |
| May 31, 2025 | 128.42% |
| Feb 28, 2025 | -300.07% |
| Nov 30, 2024 | 158.83% |
| Aug 31, 2024 | 36.75% |
| May 31, 2024 | -163.51% |
| Feb 29, 2024 | 261.50% |
| Nov 30, 2023 | 12.46% |
| Aug 31, 2023 | -144.47% |
| May 31, 2023 | 944.29% |
| Feb 28, 2023 | -222.06% |
| Nov 30, 2022 | 160.09% |
| Aug 31, 2022 | -126.09% |
| May 31, 2022 | 4.17% |
| Feb 28, 2022 | 74.03% |
| Nov 30, 2021 | -161.04% |
| Aug 31, 2021 | 810.07% |
| May 31, 2021 | -459.02% |
| Feb 28, 2021 | 101.71% |
| Nov 30, 2020 | -229.87% |
| Aug 31, 2020 | 211.67% |
| May 31, 2020 | 57.97% |
| Feb 29, 2020 | -106.35% |
| Nov 30, 2019 | -126.47% |
| Aug 31, 2019 | 528.69% |
| May 31, 2019 | -163.73% |
| Feb 28, 2019 | 1,971.46% |
| Nov 30, 2018 | -1.99% |
| Aug 31, 2018 | 134.88% |
| May 31, 2018 | 82.17% |
| Feb 28, 2018 | 60.88% |
| Nov 30, 2017 | -184.72% |
| Aug 31, 2017 | 332.36% |
| May 31, 2017 | 154.03% |
| Feb 28, 2017 | -237.73% |
| Nov 30, 2016 | 661.28% |
| Aug 31, 2016 | -33.98% |
| May 31, 2013 | 74.73% |
| Feb 28, 2013 | -34.56% |
| May 31, 2012 | -121.34% |